Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuxuening injection for unstable angina
ChiCTR1800019754Phase 4Recruiting
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Nov 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of shuxuening in unstable angina (2 arms), sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoint: Improvement in number of angina attacks. Started Nov 2018; status: recruiting.
02
Drugs
shuxuening
03
Conditions
unstable angina
Beyond the preview
Go deeper on ChiCTR1800019754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019754.